Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
Why the study?
Thromboembolic and bleeding complications remain frequent after transcatheter aortic valve implantation, but the optimal antithrombotic regimen is not known and current recommendations are mostly empirical.
What is the optimal antithrombotic therapy after transcatheter aortic valve implantation?
Population
Patients after transcatheter aortic valve implantation
Comparison
Antithrombotic treatment strategies
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Post-TAVI antithrombotic therapy lacks evidence-based guidance; leaves open optimal regimens pending ongoing trials.
Structured PICO
What is the optimal antithrombotic therapy after transcatheter aortic valve implantation?
P
Population
Patients with aortic stenosis undergoing transcatheter aortic valve implantation (TAVI)
I
Intervention
Antithrombotic therapy
This review highlights the lack of evidence-based recommendations for optimal antithrombotic therapy post-TAVI and summarizes current knowledge and ongoing trials.
Cite This Study
Lugo‐Gavidia et al. (2020) studied this question.